Kunpara Janmejay Ashvinkumar, Darji Bhavya Prakash, Patel Himanshu Arvindbhai, Patwari Devang, Patel Sujit Shaileshbhai, Darji Prakash Ishwarlal
Department of Nephrology, Zydus Hospitals, Gujarat, India.
GCS Medical College, Ahmedabad, Gujarat, India.
Indian J Nephrol. 2024 Jan-Feb;34(1):64-66. doi: 10.4103/ijn.ijn_218_22. Epub 2023 Feb 21.
Proliferative glomerulonephritis in myelofibrosis is a very rare. Mesangial proliferation and sclerosis with changes of chronic thrombotic microangiopathy have been reported, but pauci-immune focal crescentic glomerulonephritis has not been described so far. Herein, we present a 68-year-old male who was a known case of myelofibrosis and presented with rapidly progressive glomerulonephritis and nephrotic range proteinuria. He was diagnosed as anti-neutrophil cytoplasmic antibody (ANCA)-negative focal crescentic glomerulonephritis, and he responded well to a course of intravenous methylprednisolone and cyclophosphamide. Pauci-immune focal crescentic glomerulonephritis may occur in myelofibrosis without ANCA and may be related to unknown pathogenetic mechanisms in myeloproliferative disorders or suggest any superimposed pathology that might respond well to immunosuppressants.
骨髓纤维化中的增殖性肾小球肾炎非常罕见。已有关于系膜增殖和硬化伴慢性血栓性微血管病改变的报道,但迄今为止尚未描述过寡免疫性局灶性新月体性肾小球肾炎。在此,我们报告一例68岁男性,他是已知的骨髓纤维化患者,表现为快速进展性肾小球肾炎和肾病范围蛋白尿。他被诊断为抗中性粒细胞胞浆抗体(ANCA)阴性的局灶性新月体性肾小球肾炎,静脉注射甲泼尼龙和环磷酰胺一个疗程后反应良好。寡免疫性局灶性新月体性肾小球肾炎可能在无ANCA的骨髓纤维化中发生,可能与骨髓增殖性疾病中未知的发病机制有关,或提示可能对免疫抑制剂反应良好的任何叠加病理情况。